Short term thinkers?Which graph should we be looking at then? -...

Short term thinkers?
Which graph should we be looking at then? - if not the 1 day, 5 day, 3 month, 6 month, YTD, 1 Year, 3 year, 5 year, Max history.

Life-long SP history aside - my worries with LGP...

- Growing pot using the most power-hungry method possible >> in Scandinavia.
The Eu power situation is even worse than Au - ie, catastrophic.
- Heavily reliant on the European market which is about to see the same over-supply problems that have crippled the industry in Canada and are now starting to unfold in USA.
- Every Finance and Ag minister in Europe - and ALL of the 100 two-bit low-cost countries surrounding it - are "banking" on producing a million tons of pot per year for this market.
(Read all about it in the Eu industry press - and the UN development plans for the entire nearby parts of the 3rd world)
- Progress on EU regulations for all cannabis products, THC and CBD, has actually gone backwards in the past couple of months, and it is clear this will be a slower and more fraught process than the dreamers - and LGP - had ever imagined.
- Germany has just announced that its Rec market will be reserved for German producers only. Other countries are bound to follow that lead.
LGP have always claimed - including very recently - that the German rec market is important to their plans.
pfft.. gone.

- AU? I find it very difficult to see LGP holding even its current (quite small) market share in AU when you look at the comparative economics, and the natural advantages, of their soon-to-be locally producing competitors.

And into psychedelics too.
That is a sign of a deeply troubled psychology, imo.
Any TC (tiny cap) company who thinks that finding the hallucinogenic pot at the end of Timothy Leary's rainbow is the answer to their dreams needs a severe check on actual reality.

Mountains, veritable Himalayan ranges of them - will need to be moved before ANY drug company will get meaningful approvals for these super-powerful brain changers.
(go ask Compass Pathways, the leaders here. An experienced, specialist, drug development company. Market cap - 20x LGP.
Years and years... USD$500 mill and still counting... Stage 3 trials starting... soon...)
The rich and powerful "Medical Professions" are still treating these drugs as a joke - but make no mistake >> they, and Rupert Murdoch, will go the Full Nuclear when possible approvals for psychedelic drugs come closer to actual reality.

Happy to be proved wrong. I wish the company well despite my gloomy prognosis.